124 related articles for article (PubMed ID: 11240708)
1. Expression of TRAIL (TNF-related apoptosis-inducing ligand) receptors in cervical cancer.
Ryu HS; Chang KH; Chang SJ; Kim MS; Joo HJ; Oh KS
Int J Gynecol Cancer; 2000 Sep; 10(5):417-424. PubMed ID: 11240708
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of the death ligand TRAIL and its receptors.
Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
[TBL] [Abstract][Full Text] [Related]
3. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
[TBL] [Abstract][Full Text] [Related]
5. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
Zhang XD; Franco A; Myers K; Gray C; Nguyen T; Hersey P
Cancer Res; 1999 Jun; 59(11):2747-53. PubMed ID: 10364001
[TBL] [Abstract][Full Text] [Related]
6. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of TRAIL receptors using monoclonal antibodies.
Griffith TS; Rauch CT; Smolak PJ; Waugh JY; Boiani N; Lynch DH; Smith CA; Goodwin RG; Kubin MZ
J Immunol; 1999 Mar; 162(5):2597-605. PubMed ID: 10072501
[TBL] [Abstract][Full Text] [Related]
9. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Kayagaki N; Yagita H; Okumura K
Clin Exp Rheumatol; 2002; 20(6):791-8. PubMed ID: 12508770
[TBL] [Abstract][Full Text] [Related]
10. Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter.
Sträter J; Hinz U; Walczak H; Mechtersheimer G; Koretz K; Herfarth C; Möller P; Lehnert T
Clin Cancer Res; 2002 Dec; 8(12):3734-40. PubMed ID: 12473583
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer.
Ganten TM; Sykora J; Koschny R; Batke E; Aulmann S; Mansmann U; Stremmel W; Sinn HP; Walczak H
J Mol Med (Berl); 2009 Oct; 87(10):995-1007. PubMed ID: 19680616
[TBL] [Abstract][Full Text] [Related]
12. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive expression analysis of TNF-related apoptosis-inducing ligand and its receptors in colorectal cancer: Correlation with MAPK alterations and clinicopathological associations.
Tsikalakis S; Chatziandreou I; Michalopoulos NV; Theodoropoulos GE; Sakellariou S; Korkolopoulou P; Patsouris E; Saetta AA
Pathol Res Pract; 2018 Jun; 214(6):826-834. PubMed ID: 29731264
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.
Walczak H; Degli-Esposti MA; Johnson RS; Smolak PJ; Waugh JY; Boiani N; Timour MS; Gerhart MJ; Schooley KA; Smith CA; Goodwin RG; Rauch CT
EMBO J; 1997 Sep; 16(17):5386-97. PubMed ID: 9311998
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma.
Younes M; Georgakis GV; Rahmani M; Beer D; Younes A
Eur J Cancer; 2006 Mar; 42(4):542-7. PubMed ID: 16426839
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
[TBL] [Abstract][Full Text] [Related]
17. TRAIL induces death of human oligodendrocytes isolated from adult brain.
Matysiak M; Jurewicz A; Jaskolski D; Selmaj K
Brain; 2002 Nov; 125(Pt 11):2469-80. PubMed ID: 12390973
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
[TBL] [Abstract][Full Text] [Related]
20. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections.
Sträter J; Walczak H; Pukrop T; Von Müller L; Hasel C; Kornmann M; Mertens T; Möller P
Gastroenterology; 2002 Mar; 122(3):659-66. PubMed ID: 11874999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]